FDA Approves New Fast-Acting Insulin, Fiasp, for Diabetes in Adults

Share this post

The US FDA has approved ultrafast-acting mealtime insulin, Fiasp, designed to be taken just before or within 20 minutes of a meal.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply